Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04947436 · ClinicalTrials.gov registry record · NA
ALS and Airway Clearance (ALSAC) Therapy
A NA study of Amyotrophic Lateral Sclerosis and Respiratory Muscle Weakness, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT04947436: Completed NA study of Amyotrophic Lateral Sclerosis and Respiratory Muscle Weakness, sponsored by The University of Texas Health Science Center at San Antonio.
NCT04947436 is a NA study of Amyotrophic Lateral Sclerosis and Respiratory Muscle Weakness that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 28 participants, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04947436, a NA study of Amyotrophic Lateral Sclerosis and Respiratory Muscle Weakness, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients will receive one of three respiratory therapy interventions for airway clearance assistance: 1) High frequency chest wall oscillation (HFCWO) and mechanical insufflation/exsufflation (MIE), 2) HFCWO or 3) MIE. The study period will be six months and include three clinic visits, baseline and follow-up visits at 3 and 6 months, and 6 monthly home visits by the respiratory therapist.
Primary Outcome
A 9-item instrument will be used to record change from baseline to 6 months in respiratory complications. These are scored on a scale from best (no complications) to worst (death due to respiratory complications) throughout the study period. Scores range from 0-9 with a score of a 9 indicating no complications.
Conditions Studied
Interventions
- DEVICE High Frequency Chest Wall Oscillation
- DEVICE Mechanical insufflation/exsufflation
Study Locations (1)
Texas
- University of Texas Health San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-01-25 |
| Est. Completion | 2017-09-17 |
| Phase | NA |
What the finished NCT04947436 record still lists
NCT04947436 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which High Frequency Chest Wall Oscillation is the first listed.
NCT04947436 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04947436 about?
NCT04947436 is a clinical study titled "ALS and Airway Clearance (ALSAC) Therapy". Patients will receive one of three respiratory therapy interventions for airway clearance assistance: 1) High frequency chest wall oscillation (HFCWO) and mechanical insufflation/exsufflation (MIE), 2) HFCWO or 3) MIE. The study period will be six months and include three clinic visits, baseline and...
What is the current status of trial NCT04947436?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2012-01-25. Estimated completion is 2017-09-17.
What conditions does trial NCT04947436 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Respiratory Muscle Weakness.
What interventions are being tested in trial NCT04947436?
The interventions under investigation include: High Frequency Chest Wall Oscillation (DEVICE), Mechanical insufflation/exsufflation (DEVICE).
Who is sponsoring clinical trial NCT04947436?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04947436 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04947436's enrollment target sits among peer trials
28 66th of 102 higher than 35 of 102 other Amyotrophic Lateral Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALS
RECRUITING · NA
-
Precise Robotically IMplanted Brain-Computer InterfacE
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI